Holen Sie sich die Stockscreener-App
1.51
4.14%
0.06
Handel nachbörslich:
1.51
Actinium Pharmaceuticals Inc Aktie (ATNM) Neueste Nachrichten
Actinium Pharmaceuticals stock rises after promising breast cancer therapy data - Investing.com
Why is Actinium Pharmaceuticals stock rising today? - MSN
Actinium (ATNM) Reveals Promising Preclinical Data for Novel Can - GuruFocus
Why Is Actinium Pharmaceuticals Stock Rising Today? - Asianet Newsable
Actinium Pharmaceuticals Presents New Preclinical Data Demonstrating Potent Anti-Tumor Activity of ATNM-400 Across Multiple Breast Cancer Subtypes Including Hormone Receptor-Positive, Triple-Negative, and Tamoxifen- and HER2 Therapy-Resistant Br - PR Newswire
Actinium Pharmaceuticals Advances Trop-2 Targeted Alpha Radiotherapy Into Phase 1/2 Trials in the U.S. and Australia - openPR.com
Actinium Pharmaceuticals (NYSE:ATNM) Stock Price Down 0.7% – Here’s Why - Defense World
Actinium Pharmaceuticals (NYSEAMERICAN: ATNM) Begins - openPR.com
Actinium Pharmaceuticals: Clinical Milestone and Promising Data Fuel Oncology Pipeline - Ad-hoc-news.de
Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) Advances - openPR.com
Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) Advances ATNM-400 Targeting STEAP-1 Across Prostate, Breast, and Lung Cancer - marketscreener.com
ATNM-400 Targets B7-H3 and Is Being Studied in a Phase 1 Clinical Trial in South Africa - openPR.com
Actinium Pharmaceuticals Advances ATNM-400 B7-H3 Candidate Into Phase 1 Clinical Trial in South Africa - openPR.com
Can Actinium Pharmaceuticals Inc. (7AY1) stock double in coming yearsJuly 2025 Opening Moves & Safe Entry Point Alerts - Newser
Will Actinium Pharmaceuticals Inc. (Delaware) stock gain from lower interest ratesJuly 2025 Highlights & Risk Controlled Stock Alerts - Newser
Why analysts recommend Actinium Pharmaceuticals Inc. (Delaware) stock2025 Earnings Surprises & Daily Entry Point Trade Alerts - Newser
How Actinium Pharmaceuticals Inc. (Delaware) stock expands through international markets2025 Short Interest & Real-Time Chart Pattern Alerts - Newser
Will Actinium Pharmaceuticals Inc. (Delaware) stock beat Nasdaq index returnsChart Signals & Consistent Profit Alerts - Newser
Why hedge funds are buying Actinium Pharmaceuticals Inc. stockMarket Activity Report & Real-Time Volume Spike Alerts - Newser
Is Actinium Pharmaceuticals Inc. (7AY1) stock a momentum leaderJuly 2025 Volume & Fast Gain Swing Trade Alerts - Newser
Why Actinium Pharmaceuticals Inc. stock is a value investor pick2025 Market WrapUp & Expert Approved Trade Ideas - Newser
Jeri Kim: Thrilled to Join Actinium Pharmaceuticals as VP, Head of Solid Tumor Clinical Development - Oncodaily
Will Actinium Pharmaceuticals Inc. stock benefit from green energy trendsJobs Report & Daily Entry Point Alerts - Newser
Why retail traders accumulate Actinium Pharmaceuticals Inc. (Delaware) stockJuly 2025 Review & Real-Time Chart Breakout Alerts - Newser
How Actinium Pharmaceuticals Inc. (7AY1) stock valuation compares with sectorQuarterly Portfolio Summary & Weekly High Potential Alerts - Newser
How cyclical is Actinium Pharmaceuticals Inc. (7AY1) stock compared to rivalsJuly 2025 Volume & Smart Investment Allocation Insights - Newser
Actinium’s ATNM-400 shows efficacy in resistant breast cancers By Investing.com - Investing.com Australia
Actinium Pharmaceuticals (ATNM) Unveils Promising Preclinical Da - GuruFocus
Actinium's ATNM-400 shows strong efficacy in TNBC, beats therapy resistance at SABCS - marketscreener.com
Actinium’s ATNM-400 shows efficacy in resistant breast cancers - Investing.com
Actinium Pharma details ATNM-400 in resistant breast cancer | ATNM Stock News - Stock Titan
Actinium Pharmaceuticals Announces ATNM-400 Data Demonstrating Potent Efficacy in Triple-Negative Breast Cancer and Ability to Overcome Endocrine and HER2-Targeted Therapy Resistance Being Presented at the San Antonio Breast Cancer Symposiu - PR Newswire
Securities Fraud Class Action Filed Against Actinium Pharmaceutic - The National Law Review
Decliners Report: Will Actinium Pharmaceuticals Inc. stock outperform value stocksCPI Data & Safe Swing Trade Setup Alerts - BỘ NỘI VỤ
Will Actinium Pharmaceuticals Inc. stock outperform Dow Jones index2025 Market Overview & Precise Entry and Exit Recommendations - BỘ NỘI VỤ
Bull Bear: Can Actinium Pharmaceuticals Inc. stock continue upward trend2025 Retail Activity & AI Enhanced Trading Alerts - moha.gov.vn
ROSEN, A LONGSTANDING FIRM, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionATNM - 28/22 News
Actinium Pharmaceuticals elects directors and approves proposals at annual meeting - Investing.com Australia
Actinium Pharmaceuticals elects directors and approves proposals at annual meeting By Investing.com - Investing.com South Africa
Actinium Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks
Actinium ATNM holders back board, 3-year say-on-pay cycle - Stock Titan
Why institutional investors increase stakes in Actinium Pharmaceuticals Inc. (7AY1) stock - newser.com
Is Actinium Pharmaceuticals Inc. (Delaware) stock a fit for income portfoliosJuly 2025 Catalysts & Advanced Technical Signal Analysis - newser.com
How Actinium Pharmaceuticals Inc. stock benefits from global expansionMarket Trend Report & Reliable Entry Point Alerts - newser.com
HC Wainwright Has Bullish Outlook for ATNM FY2025 Earnings - Defense World
1.08%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):